Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
Editorials & Other Articles
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
A Weakness in the "Death Star" Protein, KRAS.
This little bit came in on my Nature News Newsfeed with a link to a popular article:
Death Star’ protein has a weak spot
Researchers have identified a second weakness in a cancer-promoting protein called KRAS. An analysis of 26,000 mutations revealed two vulnerable spots in the protein: one that has already been exploited by existing KRAS inhibitors, and a novel location called cavity 3. Like the Death Star from Star Wars, the KRAS was thought to be impenetrable — but a complete blueprint of the spherical protein has helped researchers to find a rare weak point.
Researchers have identified a second weakness in a cancer-promoting protein called KRAS. An analysis of 26,000 mutations revealed two vulnerable spots in the protein: one that has already been exploited by existing KRAS inhibitors, and a novel location called cavity 3. Like the Death Star from Star Wars, the KRAS was thought to be impenetrable — but a complete blueprint of the spherical protein has helped researchers to find a rare weak point.
It refers to this popular science article:
Researchers discover the weak points of the protein that causes one in 10 cancers
Subtitle:
Four scientists from Barcelona have created the first map of the vulnerable sites of the KRAS gene, whose mutations, often associated with smoking, cause millions of tumors
Some excerpts from the popular article:
One in two men and almost one in three women will have cancer during their lifetime. In at least one in 10 cases, the tumor will be driven by mutations in the KRAS gene, discovered in 1982, but so devilishly complex that the scientific community has spent four decades trying to find its Achilles. Mutations in KRAS are behind almost 90% of pancreatic cancer cases, 40% of colon cancers and 35% of lung cancers. A team from the Center for Genomic Regulation in Barcelona has finally managed to create a complete map of its weaknesses. A preview of the research was published Monday in the journal Nature, a showcase of the best world science.
Genes are stretches of DNA with the instructions for making a protein. The KRAS gene is the manual for generating the KRAS protein, a kind of switch that causes the cell to divide. Uncontrolled activation of KRAS causes cells to run amok, multiply and cause cancer. For decades, it seemed impossible to target this protein with drugs. However, in 2021, the U.S. pharmaceutical company Amgen received FDA approval for sotorasib, an effective drug against lung cancer in people who have a specific mutation in the KRAS gene, which is associated with damage caused by smoking. Biochemist Ray Deshaies, scientific vice-president of Amgen, explained at a press conference that “[the delay of over four decades] wasn’t because we didn’t know what we wanted to do, which was inhibit the mutation in KRAS, it’s just that we had no idea how to do it...”
...The authors of the new study explain that the KRAS protein is like the Death Star, the unconquerable space station from the Star Wars film saga. “The protein is quite spherical and has very few sites that you could imagine as binding points for a drug,” says South African bioinformatician André Faure, who works at the Barcelona institution. “It was considered to be impenetrable,” emphasizes his colleague Albert Escobedo. In the movie Star Wars, the good guys got a blueprint of the Death Star and the hero Luke Skywalker managed to hit its only weak point. The Center for Genomic Regulation team has now obtained the complete blueprint of KRAS...
Genes are stretches of DNA with the instructions for making a protein. The KRAS gene is the manual for generating the KRAS protein, a kind of switch that causes the cell to divide. Uncontrolled activation of KRAS causes cells to run amok, multiply and cause cancer. For decades, it seemed impossible to target this protein with drugs. However, in 2021, the U.S. pharmaceutical company Amgen received FDA approval for sotorasib, an effective drug against lung cancer in people who have a specific mutation in the KRAS gene, which is associated with damage caused by smoking. Biochemist Ray Deshaies, scientific vice-president of Amgen, explained at a press conference that “[the delay of over four decades] wasn’t because we didn’t know what we wanted to do, which was inhibit the mutation in KRAS, it’s just that we had no idea how to do it...”
...The authors of the new study explain that the KRAS protein is like the Death Star, the unconquerable space station from the Star Wars film saga. “The protein is quite spherical and has very few sites that you could imagine as binding points for a drug,” says South African bioinformatician André Faure, who works at the Barcelona institution. “It was considered to be impenetrable,” emphasizes his colleague Albert Escobedo. In the movie Star Wars, the good guys got a blueprint of the Death Star and the hero Luke Skywalker managed to hit its only weak point. The Center for Genomic Regulation team has now obtained the complete blueprint of KRAS...
The full scientific paper, which is not in a finalized form but is provided on an "ASAP" basis, referring to allosteric sites is here: Weng, C., Faure, A.J., Escobedo, A. et al. The energetic and allosteric landscape for KRAS inhibition. Nature (2023)
3 replies
= new reply since forum marked as read
= new reply since forum marked as read
